Senator calls for investigation of Purdue Pharma following Times story on OxyContin – LA Times #pharma #recruitment #agencies

Posted On Apr 27 2017 by

#purdue pharmaceuticals # Senator calls for investigation of Purdue Pharma following Times story on OxyContin A U.S. senator on Friday called for federal investigations of OxyContin s manufacturer in response to a Los Angeles Times report that found the bestselling painkiller wears off early in many patients, exposing them to increased risk of addiction. Sen. Edward J. Markey, a Massachusetts Democrat whose state has been hit hard by prescription drug abuse, urged the Justice Department. the Food and Drug Administration and the Federal Trade Commission to launch probes of drugmaker Purdue Pharma. OxyContin s main selling point is that it …


AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices #pharma #blog

Posted On Mar 21 2017 by

#pharmaceutical advertising # AMA News Room AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices For immediate release: Nov. 17, 2015 ATLANTA Responding to the billions of advertising dollars being spent to promote prescription products, physicians at the Interim Meeting of the American Medical Association (AMA) today adopted new policy aimed at driving solutions to make prescription drugs more affordable. Physicians cited concerns that a growing proliferation of ads is driving demand for expensive treatments despite the clinical effectiveness of less costly alternatives. Today s vote in support of an advertising ban reflects concerns …


Senator calls for investigation of Purdue Pharma following Times story on OxyContin – LA Times #pharmaceutical #manufacturer

Posted On Jan 26 2017 by

#purdue pharmaceuticals # Senator calls for investigation of Purdue Pharma following Times story on OxyContin A U.S. senator on Friday called for federal investigations of OxyContin s manufacturer in response to a Los Angeles Times report that found the bestselling painkiller wears off early in many patients, exposing them to increased risk of addiction. Sen. Edward J. Markey, a Massachusetts Democrat whose state has been hit hard by prescription drug abuse, urged the Justice Department. the Food and Drug Administration and the Federal Trade Commission to launch probes of drugmaker Purdue Pharma. OxyContin s main selling point is that it …


Senator calls for investigation of Purdue Pharma following Times story on OxyContin – LA Times #bsp #pharma #inc

Posted On Nov 21 2016 by

#purdue pharmaceuticals # Senator calls for investigation of Purdue Pharma following Times story on OxyContin A U.S. senator on Friday called for federal investigations of OxyContin s manufacturer in response to a Los Angeles Times report that found the bestselling painkiller wears off early in many patients, exposing them to increased risk of addiction. Sen. Edward J. Markey, a Massachusetts Democrat whose state has been hit hard by prescription drug abuse, urged the Justice Department. the Food and Drug Administration and the Federal Trade Commission to launch probes of drugmaker Purdue Pharma. OxyContin s main selling point is that it …


Senator calls for investigation of Purdue Pharma following Times story on OxyContin – LA Times #shionogi #pharma #inc

Posted On Nov 2 2016 by

#purdue pharmaceuticals # Senator calls for investigation of Purdue Pharma following Times story on OxyContin A U.S. senator on Friday called for federal investigations of OxyContin s manufacturer in response to a Los Angeles Times report that found the bestselling painkiller wears off early in many patients, exposing them to increased risk of addiction. Sen. Edward J. Markey, a Massachusetts Democrat whose state has been hit hard by prescription drug abuse, urged the Justice Department. the Food and Drug Administration and the Federal Trade Commission to launch probes of drugmaker Purdue Pharma. OxyContin s main selling point is that it …


Senator calls for investigation of Purdue Pharma following Times story on OxyContin – LA Times #marketing #pharmaceuticals

Posted On Oct 27 2016 by

#purdue pharmaceuticals # Senator calls for investigation of Purdue Pharma following Times story on OxyContin A U.S. senator on Friday called for federal investigations of OxyContin s manufacturer in response to a Los Angeles Times report that found the bestselling painkiller wears off early in many patients, exposing them to increased risk of addiction. Sen. Edward J. Markey, a Massachusetts Democrat whose state has been hit hard by prescription drug abuse, urged the Justice Department. the Food and Drug Administration and the Federal Trade Commission to launch probes of drugmaker Purdue Pharma. OxyContin s main selling point is that it …


Senator calls for investigation of Purdue Pharma following Times story on OxyContin – LA Times #merck #pharma

Posted On Oct 4 2016 by

#purdue pharmaceuticals # Senator calls for investigation of Purdue Pharma following Times story on OxyContin A U.S. senator on Friday called for federal investigations of OxyContin s manufacturer in response to a Los Angeles Times report that found the bestselling painkiller wears off early in many patients, exposing them to increased risk of addiction. Sen. Edward J. Markey, a Massachusetts Democrat whose state has been hit hard by prescription drug abuse, urged the Justice Department. the Food and Drug Administration and the Federal Trade Commission to launch probes of drugmaker Purdue Pharma. OxyContin s main selling point is that it …


AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices

Posted On Sep 29 2016 by

#pharmaceutical advertising # AMA News Room AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices For immediate release: Nov. 17, 2015 ATLANTA Responding to the billions of advertising dollars being spent to promote prescription products, physicians at the Interim Meeting of the American Medical Association (AMA) today adopted new policy aimed at driving solutions to make prescription drugs more affordable. Physicians cited concerns that a growing proliferation of ads is driving demand for expensive treatments despite the clinical effectiveness of less costly alternatives. Today s vote in support of an advertising ban reflects concerns …